查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997201

离心式血液帮浦市场：按帮浦类型、流量、材质、应用和最终用户划分－2026-2032年全球市场预测

Centrifugal Blood Pumps Market by Pump Type, Flow Rate, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，离心式血液帮浦市场价值将达到 9,302 万美元，到 2026 年将成长至 1.0427 亿美元，到 2032 年将达到 1.5646 亿美元，年复合成长率为 7.71%。

主要市场统计数据
基准年 2025 9302万美元
预计年份：2026年 1.0427亿美元
预测年份 2032 1.5646亿美元
复合年增长率 (%) 7.71%

简要概述了影响离心式血液帮浦采购决策的核心技术、临床作用和性能特征。

离心式血泵集血流动力学支持、紧凑的面积以及与先进体外循环系统的兼容性于一体，已成为急性心臟护理各个环节中不可或缺的组成部分。本文阐述了现代离心式血泵设计的技术基础，重点在于流体动态、磁浮和机械轴承结构，并说明了这些技术如何影响血流特性、血液相容性和设备耐久性。此外，本文还概述了这些血液泵发挥关键作用的临床应用，包括心臟手术术前术后支持、长期体外膜氧合（ECMO）治疗以及短期至长期心室辅助装置（VAD）。

更严格的法规、临床需求和快速的技术进步如何重塑离心式血液帮浦的开发、商业化和临床应用。

离心式血液帮浦领域正经历一场变革，其驱动因素包括临床实务、监管和技术创新。临床上，患者群体老化以及机械循环和体外循环支持适应症的不断扩大，推动了对兼顾疗效和安全性的器械的需求。同时，监管机构正在加强上市后监管和器械检验要求，迫使製造商加强对耐久性测试、血液相容性测试和真实世界临床数据项目的投入。这些监管变化正在加速从传统机械轴承设计到磁浮和先进流体动态系统的转变，从而显着降低血液损伤和维护负担。

2025 年的关税环境将迫使供应链重组，供应商本地化，并筹资策略，以确保临床的连续性和成本的稳定性。

2025年实施的新关税措施使医疗设备相关人员的跨境供应链和筹资策略变得更加复杂，对依赖国际采购零件和成品的公司影响尤为显着。关税调整提高了进口特殊金属、精密轴承和聚合物化合物等原材料的製造商的成本基础，加速了供应商关係和成本工程方法的重新评估。为此，一些製造商正在加快供应商认证计划，尽可能实现生产本地化，并重组物流系统，以最大限度地减少关税对最终用户的影响。

整合细分智能，识别临床适应症、最终用户概况、泵浦技术、流量模式和材料选择交叉的领域，从而确定采购优先事项。

细分市场层面的洞察揭示了临床需求与技术能力最紧密交汇的点。对特定应用趋势的评估表明，心臟外科手术、体外膜氧合（ECMO）和心室瓣膜支撑装置是三个不同的需求领域。 ECMO 又细分为体外二氧化碳清除、静脉-动脉 ECMO 和静脉-静脉 ECMO，每种 ECMO 对流量和耐久性都有其独特的需求。心室瓣膜支撑装置分为双心室、左心室和右心室支撑配置，每种配置都需要相应的控制策略和轴承技术。

美洲、欧洲、中东和非洲以及亚太地区的区域部署模式、还款状况和供应链趋势都会影响设备的采用。

区域趋势正在影响整个离心式血泵市场的采用模式、报销机制和供应链韧性。在美洲，先进的三级医疗机构和专科心臟病医院在完善的报销机制和紧密的临床网络的支持下，推动了离心式血泵的早期临床应用，这些机制和网络促进了技术的传播。这些机构发挥创新中心的作用，产生真实世界数据和治疗通讯协定，并透过区域转诊系统进行推广。同时，在小规模的医院和门诊中心，成本控制压力和集中采购机制正在影响设备的选择。

竞争趋势着重于临床证据服务网络和技术合作，这使得现有製造商、专业公司和颠覆性参与企业。

竞争格局由成熟的医疗设备製造商、专业製造商以及专注于差异化泵浦架构和服务模式的新兴技术参与企业组成。市场领导强调提供临床证据、建立广泛的服务网络，并为灌注师和手术团队提供全面培训计画。中型企业则倾向于工程柔软性和上市速度竞争，利用模组化设计和高度适应性的控制系统来满足特定的临床需求。

为製造商、供应商和买家提供切实可行的策略行动，以改善临床结果、确保供应弹性并建立灵活的商业性方法。

产业领导者应优先致力于改善临床疗效，同时稳定供应和成本结构。首先，他们应投资于强有力的临床证据项目，量化血液相容性、设备耐用性和以患者为中心的疗效，尤其是在心臟手术、体外膜肺氧合（ECMO）亚型和心室辅助装置（VAD）配置等关键应用领域。已证实的临床获益仍是协调部署和报销方案的最有力论点。其次，他们应加强供应商多元化和近岸外包策略，以减轻关税对成本波动的影响，同时确保关键金属和聚合物零件的品质。

为了支持我们的结论，我们采用了一种透明的混合方法研究框架，该框架结合了对临床相关人员的初步访谈、技术评估和供应链分析。

本研究整合了多种证据来源，以提供稳健的分析基础。主要资料收集包括对不同医院环境和区域市场的临床医生、体外循环技师、采购负责人和製造工程师进行结构化访谈。这些访谈提供了对临床工作流程、设备整合挑战和服务需求的定性评估。次要研究着重于同侪审查的血液相容性文献、监管指导文件、轴承技术和材料科学方面的技术白皮书以及产品特定的技术规范，以检验性能声明。

摘要重点阐述了临床有效性、供应弹性和卓越服务之间的相互作用，这些因素决定了医疗设备的长期部署。

总之，离心式血泵正处于临床需求与技术创新交会的十字路口。儘管现代设计趋势倾向于优先考虑血液相容性、高反应控制系统以及降低整个生命週期的负担，但监管和关税压力正迫使製造商重新思考其供应链和循证策略。从门诊手术中心到三级医院，终端使用者需要能够适应当地临床工作流程、人员配备和整体营运需求的解决方案，因此，服务能力和培训与设备性能同等重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 离心式血液帮浦市场：依帮浦类型划分

  • 流体轴承
  • 磁浮
  • 机械轴承

第九章 依流量分類的离心式血液帮浦市场

  • 高流速
  • 低流量
  • 中等流速

第十章 离心式血液帮浦市场：依材料分类

  • 金属
  • 聚合物

第十一章 离心式血液帮浦市场：依应用领域划分

  • 心臟外科手术
  • 体外膜氧合（ECMO）
    • 外部二氧化碳移除
    • 静脉-动脉体外膜氧合（ECMO）
    • 静脉-静脉体外膜氧合（ECMO）
  • 心室辅助装置
    • 双心室辅助装置
    • 左心室辅助装置
    • 右心室辅助装置

第十二章 离心式血液帮浦市场：依最终用户划分

  • 门诊手术中心
  • 医院
    • 心臟医疗中心
    • 综合医院
    • 三级医疗医院
  • 研究机构

第十三章 离心式血液帮浦市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 离心式血泵市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 离心式血液帮浦市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国离心式血液帮浦市场

第十七章：中国离心式血液帮浦市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Artimedica
  • Baxter International Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • Eurosets Srl
  • Fresenius Medical Care
  • Getinge AB
  • LivaNova Plc
  • Medos Medizintechnik AG
  • Medtronic Plc
  • Qura Srl
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Terumo Corporation
Product Code: MRR-C27187914397

The Centrifugal Blood Pumps Market was valued at USD 93.02 million in 2025 and is projected to grow to USD 104.27 million in 2026, with a CAGR of 7.71%, reaching USD 156.46 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 93.02 million
Estimated Year [2026] USD 104.27 million
Forecast Year [2032] USD 156.46 million
CAGR (%) 7.71%

A concise foundational overview explaining centrifugal blood pump core technologies clinical roles and the performance attributes that drive procurement decisions

Centrifugal blood pumps have become foundational components across acute cardiac care pathways, offering a blend of hemodynamic support, compact footprints, and compatibility with advanced extracorporeal circulatory systems. This introduction defines the technological underpinnings of contemporary centrifugal designs, emphasizing hydrodynamic, magnetic levitation, and mechanical bearing architectures and how these approaches affect flow characteristics, hemocompatibility, and device longevity. It also frames the clinical applications where these pumps are most consequential, including perioperative cardiac surgery support, prolonged extracorporeal membrane oxygenation (ECMO) therapy, and short- to long-term ventricular assist device (VAD) applications.

Clinical demands, device miniaturization, and evolving regulatory expectations have collectively reshaped design priorities. As a result, stakeholders must reconcile competing objectives: minimizing shear stress and thrombogenicity while maintaining reliable flow delivery across a spectrum of patient sizes and pathophysiologies. This section outlines the primary performance attributes clinicians and procurement teams evaluate: flow stability at high, medium, and low rates; bearing and rotor technology trade-offs; and material selection between metallic and polymeric components. By clarifying these core concepts up front, the report prepares readers to interpret downstream sections on market dynamics, segmentation insights, and strategic recommendations.

How regulatory tightening clinical demand and rapid technology advances are reshaping centrifugal blood pump development commercialization and clinical adoption

The centrifugal blood pump landscape is undergoing transformative shifts driven by converging forces in clinical practice, regulatory scrutiny, and technological innovation. Clinically, an aging patient population and expanded indications for mechanical circulatory and extracorporeal support have increased demand for devices that balance efficacy with safety. Regulatory authorities have concurrently tightened post-market surveillance and device validation expectations, prompting manufacturers to invest more in durability testing, hemocompatibility studies, and real-world evidence programs. These regulatory shifts accelerate transitions from legacy mechanical-bearing designs toward magnetic levitation and advanced hydrodynamic systems that can demonstrably reduce blood trauma and maintenance burdens.

Technological innovation is equally pivotal. Advances in computational fluid dynamics, sensor integration, and closed-loop control systems enhance pump responsiveness and reduce clinician workload. Materials science developments provide new polymer formulations and coatings designed to resist protein adhesion and thrombus formation, while additive manufacturing enables bespoke components and reduced time-to-prototype. As stakeholders adopt remote monitoring and telemetric diagnostics, pumps increasingly function as nodes within broader care ecosystems, enabling earlier detection of adverse trends and facilitating outpatient management strategies that were previously infeasible. Taken together, these shifts create a landscape where strategic differentiation is rooted in demonstrable clinical outcomes, integrated digital capabilities, and a robust evidence base.

The 2025 tariff environment forcing supply chain realignment supplier localization and procurement strategies to protect clinical continuity and cost stability

The introduction of new tariff measures in 2025 has complicated cross-border supply chains and procurement strategies for medical device stakeholders, particularly those that rely on international sourcing of components or finished products. Tariff adjustments have elevated the cost base for manufacturers that import raw materials such as specialty metals, precision bearings, and polymer compounds, thereby incentivizing a reassessment of supplier relationships and cost-engineering approaches. In response, several manufacturers have accelerated supplier qualification programs, localized production where feasible, and restructured logistics to minimize the tariff impact on end users.

Importantly, the tariff environment has also shifted the calculus for tendering organizations and hospital procurement teams. Buyers are increasingly evaluating total landed cost and long-term service agreements rather than unit price alone. This shift has emphasized the value proposition of devices offering lower lifecycle maintenance, fewer consumable replacements, and extended warranties. Meanwhile, partnerships between device manufacturers and regional distributors are evolving to include flexible pricing models and consignment arrangements that mitigate near-term budgetary pressures. Overall, tariffs have catalyzed a series of operational responses that prioritize supply resilience, vertical integration, and contractual structures designed to protect clinical continuity amid pricing volatility.

Integrated segmentation intelligence revealing where clinical indications end-user profiles pump technologies flow regimes and material choices converge to shape procurement priorities

Segment-level insights reveal where clinical need and technological capability intersect most strongly. When assessing application-specific dynamics, cardiac surgery, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices emerge as distinct demand domains. ECMO subdivides into extracorporeal carbon dioxide removal, veno-arterial ECMO, and veno-venous ECMO, each with unique flow and durability requirements. Ventricular assist devices bifurcate into bi-ventricular, left ventricular, and right ventricular assist configurations, demanding tailored control strategies and bearing technologies.

End-user segmentation shows that ambulatory surgical centers, hospitals, and research institutes drive different procurement priorities. Within hospitals, cardiac specialty centers, general hospitals, and tertiary care hospitals exhibit divergent needs for device complexity, inventory depth, and on-site technical support. Pump type segmentation highlights the trade-offs between hydrodynamic bearing designs, magnetic levitation systems, and mechanical bearings, with each type offering distinct performance, maintenance, and hemocompatibility profiles. Flow-rate segmentation-high, medium, and low-further clarifies device suitability for acute versus chronic support and for adult versus pediatric applications. Material segmentation between metal and polymer components underscores considerations around weight, durability, manufacturability, and biocompatibility. Together, these segmentation lenses provide a composite view that helps clinicians and purchasers match technology attributes to clinical workflows and institutional capabilities.

Regional adoption patterns reimbursement realities and supply chain dynamics across the Americas Europe Middle East & Africa and Asia-Pacific shaping device uptake

Regional dynamics influence adoption patterns, reimbursement frameworks, and supply chain resilience across the centrifugal blood pump landscape. In the Americas, advanced tertiary centers and cardiac specialty hospitals drive early clinical adoption, supported by established reimbursement mechanisms and dense clinical networks that facilitate technology diffusion. These centers act as innovation hubs, generating real-world evidence and procedural protocols that propagate through regional referral systems. Conversely, cost containment pressures and procurement centralization mechanisms influence device selection in smaller hospitals and ambulatory centers.

Europe, Middle East & Africa presents a heterogeneous environment where regulatory harmonization efforts coexist with disparate procurement models. High-capability centers in western Europe often lead in clinical trials and post-market surveillance initiatives, while emerging markets in the region prioritize affordability and supply chain reliability. In Asia-Pacific, rapid hospital expansion, growing investment in critical care, and increasing local manufacturing capacity shape a competitive environment that emphasizes scalability and localization. Across all regions, strategic partnerships between manufacturers and regional distributors, as well as localized service capabilities, determine the ease of adoption and long-term device uptime.

Competitive dynamics spotlighting clinical evidence service networks and technology partnerships that differentiate incumbent manufacturers specialized firms and disruptive entrants

The competitive landscape is driven by a mix of established medical device firms, specialized manufacturers, and emerging technology entrants that focus on differentiated pump architectures and service models. Market leaders emphasize clinical evidence generation, extensive service networks, and integrated training programs for perfusionists and surgical teams. Mid-size players often compete on engineering flexibility and speed-to-market, leveraging modular designs and adaptable control systems to meet niche clinical requirements.

New entrants are frequently technology-centric, emphasizing magnetic levitation, compact hydrodynamic designs, or digital monitoring features that enable predictive maintenance. Across the spectrum, strategic partnerships between device manufacturers and component suppliers-particularly for precision bearings and hemocompatible materials-play a pivotal role in sustaining product reliability. Mergers, acquisitions, and licensing agreements remain common as companies seek to expand their clinical footprints, extend product portfolios, and secure technology advantages in sensor integration and telemetry. Service agreements, training offerings, and warranty structures increasingly differentiate vendors in procurement discussions.

Practical strategic actions for manufacturers providers and purchasers to enhance clinical outcomes secure supply resilience and create flexible commercial approaches

Industry leaders should prioritize initiatives that enhance clinical outcomes while stabilizing supply and cost structures. First, invest in robust clinical evidence programs that quantify hemocompatibility, device durability, and patient-centered outcomes across the primary application areas of cardiac surgery, ECMO subtypes, and VAD configurations. Demonstrable clinical benefit remains the most persuasive argument for adoption and reimbursement alignment. Second, strengthen supplier diversification and nearshoring strategies to reduce exposure to tariff-driven cost volatility while maintaining quality assurance for critical metallic and polymer components.

Third, expand service and training ecosystems to ensure consistent device performance across ambulatory centers, general hospitals, cardiac specialty centers, and tertiary institutions. This includes remote monitoring capabilities and predictive maintenance programs tied to telemetry and analytics. Fourth, accelerate material and bearing innovation by prioritizing low-shear rotor profiles, hemocompatible coatings, and validated polymer alternatives where appropriate. Finally, pursue flexible commercial models-such as outcome-linked payments, extended warranties, and consignment arrangements-to lower adoption barriers for budget-constrained institutions and to align long-term incentives between suppliers and healthcare providers.

A transparent mixed-methods research framework combining primary clinician stakeholder interviews technical evaluation and supply chain analysis to underpin conclusions

This research synthesizes multiple evidence streams to provide a robust analytical foundation. Primary data collection included structured interviews with clinicians, perfusionists, procurement professionals, and manufacturing engineers across diverse hospital settings and regional markets. These conversations informed qualitative assessments of clinical workflows, device integration challenges, and service requirements. Secondary research encompassed peer-reviewed literature on hemocompatibility, regulatory guidance documents, technical whitepapers on bearing technologies and materials science, and product-specific technical specifications to validate performance claims.

Analytical methods combined thematic synthesis of qualitative insights with comparative technical evaluation of pump architectures. Supply chain analyses assessed component sourcing pathways, logistics configurations, and tariff impacts. Regional adoption patterns were examined through a cross-sectional review of healthcare infrastructure indicators and hospital capacity trends. Throughout, the methodology emphasized transparency in source triangulation and critical appraisal of vendor-provided claims. Where applicable, sensitivity testing and scenario analysis clarified how shifts in tariffs, regulatory expectations, or clinical practice patterns could influence operational strategies without relying on proprietary numeric projections.

Closing synthesis emphasizing the interplay between clinical validation supply resilience and service excellence that will determine long-term device adoption

In conclusion, centrifugal blood pumps are positioned at the intersection of clinical necessity and engineering innovation. Contemporary trends favor designs that prioritize hemocompatibility, responsive control systems, and lower lifecycle burdens, while regulatory and tariff pressures are prompting manufacturers to rethink supply chains and evidence-generation strategies. End users-from ambulatory surgical centers to tertiary care hospitals-require solutions that align with local clinical workflows, staffing levels, and total operational demands, making service capability and training as important as device performance.

Looking ahead, stakeholders that combine rigorous clinical validation with resilient production strategies and adaptable commercial models will be best placed to meet evolving institutional priorities. Device developers that invest in material science, bearing technology, and integrated monitoring will create tangible differentiation, and purchasers that emphasize total cost of ownership and service continuity will better safeguard patient outcomes. This balance of clinical evidence, operational resilience, and user-centric support will determine which technologies achieve sustained adoption across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Centrifugal Blood Pumps Market, by Pump Type

  • 8.1. Hydrodynamic Bearing
  • 8.2. Magnetic Levitation
  • 8.3. Mechanical Bearing

9. Centrifugal Blood Pumps Market, by Flow Rate

  • 9.1. High Flow
  • 9.2. Low Flow
  • 9.3. Medium Flow

10. Centrifugal Blood Pumps Market, by Material

  • 10.1. Metal
  • 10.2. Polymer

11. Centrifugal Blood Pumps Market, by Application

  • 11.1. Cardiac Surgery
  • 11.2. Extra Corporeal Membrane Oxygenation
    • 11.2.1. Extra Corporeal CO2 Removal
    • 11.2.2. Veno Arterial ECMO
    • 11.2.3. Veno Venous ECMO
  • 11.3. Ventricular Assist Devices
    • 11.3.1. Bi Ventricular Assist Devices
    • 11.3.2. Left Ventricular Assist Devices
    • 11.3.3. Right Ventricular Assist Devices

12. Centrifugal Blood Pumps Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
    • 12.2.1. Cardiac Specialty Centers
    • 12.2.2. General Hospitals
    • 12.2.3. Tertiary Care Hospitals
  • 12.3. Research Institutes

13. Centrifugal Blood Pumps Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Centrifugal Blood Pumps Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Centrifugal Blood Pumps Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Centrifugal Blood Pumps Market

17. China Centrifugal Blood Pumps Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Artimedica
  • 18.7. Baxter International Inc.
  • 18.8. Berlin Heart GmbH
  • 18.9. BiVACOR Inc.
  • 18.10. Braile Biomedica Ltd.
  • 18.11. Eurosets S.r.l.
  • 18.12. Fresenius Medical Care
  • 18.13. Getinge AB
  • 18.14. LivaNova Plc
  • 18.15. Medos Medizintechnik AG
  • 18.16. Medtronic Plc
  • 18.17. Qura Srl
  • 18.18. Senko Medical Instrument Mfg. Co., Ltd.
  • 18.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HYDRODYNAMIC BEARING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HYDRODYNAMIC BEARING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HYDRODYNAMIC BEARING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MAGNETIC LEVITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MAGNETIC LEVITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MAGNETIC LEVITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MECHANICAL BEARING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MECHANICAL BEARING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MECHANICAL BEARING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HIGH FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HIGH FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HIGH FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LOW FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LOW FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LOW FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MEDIUM FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MEDIUM FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MEDIUM FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL CO2 REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL CO2 REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL CO2 REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO ARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO ARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO ARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO VENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO VENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO VENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY BI VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY BI VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY BI VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)